English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Ruth de Jauregui | May 7, 2017

Data from multiple sclerosis medication study shows promise

+ Technology/Innovation
Ruth de Jauregui | May 7, 2017

Sanfoli Genzyme releases 6 years of data on Lemtrada in patients with relapsing remitting multiple sclerosis

+ Technology/Innovation
Ruth de Jauregui | May 7, 2017

Survey finds majority of rheumatoid arthritis patients living in pain

+ Technology/Innovation
Chandra Lye | May 5, 2017

GSK takes steps to boost production of systemic lupus erthermatosus medication

+ Regulatory
John Breslin | May 5, 2017

Republican health care bill 'will evolve' in the Senate, policy expert says

+ Community
Ruth de Jauregui | May 5, 2017

Johnson & Johnson launches new stress management program

+ Regulatory
Chandra Lye | May 4, 2017

FDA approves use of Ravicti to treat urea cycle disorders in younger pediatric patients

+ Technology/Innovation
Chandra Lye | May 4, 2017

Drug offers hope for children with rare brain disease

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns

  • « First
  • «
  • …
  • 391
  • 392
  • 393
  • 394
  • 395
  • 396
  • 397
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily